Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe data regarding the safety and efficacy of novel therapies for chronic hepatitis C in treatment-naive and treatment-experienced patients
- Discuss the use of virologic response to determine optimal duration of hepatitis C virus therapy
- Recount data regarding predictors of response to hepatitis C virus therapy
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.